Literature DB >> 18057294

Pulmonary arterial coil embolization for the management of persistent type I hepatopulmonary syndrome after liver transplantation.

Nael E A Saad1, David E Lee, David L Waldman, Wael E A Saad.   

Abstract

Hepatopulmonary syndrome (HPS) is a common complication of chronic liver disease. The definitive therapy is liver transplantation. Medical management, transjugular intrahepatic portosystemic shunt creation, and pulmonary arterial coil embolization have been described as temporizing measures until liver transplantation is performed. In earlier studies, the degree of right-to-left shunting in HPS has been shown to be an indicator of posttransplantation morbidity and mortality. The present article describes a case of type I HPS managed by liver transplantation and augmented by posttransplantation pulmonary arterial coil embolization to reduce the patient's posttransplantation morbidity.

Entities:  

Mesh:

Year:  2007        PMID: 18057294     DOI: 10.1016/j.jvir.2007.08.008

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  12 in total

Review 1.  Hepatopulmonary syndrome: What we know and what we would like to know.

Authors:  Israel Grilo-Bensusan; Juan Manuel Pascasio-Acevedo
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

Review 2.  Portopulmonary hypertension and hepatopulmonary syndrome.

Authors:  Florence Aldenkortt; Marc Aldenkortt; Laurence Caviezel; Jean Luc Waeber; Anne Weber; Eduardo Schiffer
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

3.  The role of garlic in hepatopulmonary syndrome: a randomized controlled trial.

Authors:  Binay K De; Deep Dutta; Subrata K Pal; Subhabrata Gangopadhyay; Sumanta Das Baksi; Adyapad Pani
Journal:  Can J Gastroenterol       Date:  2010-03       Impact factor: 3.522

Review 4.  Hepatopulmonary Syndrome.

Authors:  Yong Lv; Daiming Fan
Journal:  Dig Dis Sci       Date:  2015-03-03       Impact factor: 3.199

Review 5.  Hepatopulmonary syndrome: update on pathogenesis and clinical features.

Authors:  Junlan Zhang; Michael B Fallon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-07-03       Impact factor: 46.802

6.  Hepatopulmonary Syndrome and Portopulmonary Hypertension: Current Status and Implications for Liver Transplantation.

Authors:  Kelley Weinfurtner; Kimberly Forde
Journal:  Curr Hepatol Rep       Date:  2020-07-11

7.  Pulmonary artery embolotherapy in a patient with type I hepatopulmonary syndrome after liver transplantation.

Authors:  Hae Won Lee; Kyung-Suk Suh; Joohyun Kim; Woo Young Shin; Nam-Joon Yi; Hwan Jun Jae; Jin Wook Chung; So Won Oh; Keon Wook Kang; Kuhn Uk Lee
Journal:  Korean J Radiol       Date:  2010-06-21       Impact factor: 3.500

Review 8.  Pulmonary complications of hepatic diseases.

Authors:  Salim R Surani; Yamely Mendez; Humayun Anjum; Joseph Varon
Journal:  World J Gastroenterol       Date:  2016-07-14       Impact factor: 5.742

9.  Pulmonary vascular complications of chronic liver disease: Pathophysiology, imaging, and treatment.

Authors:  Ali Nawaz Khan; Hamdan Al-Jahdali; Khalid Abdullah; Klaus L Irion; Quratulain Sabih; Alaa Gouda
Journal:  Ann Thorac Med       Date:  2011-04       Impact factor: 2.219

10.  Management of cardiopulmonary complications of cirrhosis.

Authors:  Prabha Sawant; C Vashishtha; M Nasa
Journal:  Int J Hepatol       Date:  2011-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.